Tag : hemp cbd

Current News Hemp News Market Watch

GW Pharma’s CBD Pharmaceutical, Epidiolex, Shows Results in Lowering Seizures in Clinical Trials

Editor
GW Pharmaceuticals (Nasdaq: GWPH) has announced this morning that their company has completed a double-blind, placebo-controlled Phase 3 clinical trial for its Cannabidiol (CBD) derived product EPIDIOLEX®. The clinical results have shown that their product has significantly helped patients with Dravet syndrome treat and reduce their seizures associated with the...
Hemp News Market Watch

Curaleaf Launches Hemp-Derived CBD Product Line in the U.S.

Editor
Curaleaf, Inc. (CSE: CURA) has announced this morning that the company is planning to launch their own line of domestically grown premium hemp-derived Cannabidiol (CBD) products called, Curaleaf Hemp. Their new product line will be distributed throughout the United States. Currently, Curaleaf operates 33 cannabis dispensaries, 12 cultivation sites and...
Hemp News Market Watch

MariMed Enters Strategic Partnership with Hemp CBD Producer GenCanna

Editor
MariMed Inc. (OTCQB: MRMD) has announced this morning that the company has created a strategic partnership with GenCannaGlobal Inc. Under the terms of the agreement the two companies have entered into a long-term supply agreement in which MariMed will be receiving hemp derived CBD oil from the Kentucky hemp producer GenCannaGlobal....
Hemp News Market Watch

CV Sciences, Inc. Sells $13.6 Million Worth of CBD Products in Q3

Editor
CV Sciences, Inc. (OTCQB:CVSI) has announced this morning the company’s Q3 financials for 2018. Their hemp derived Cannbidiol (CBD) product brand +CBD Oil is one of the most popular in the United States. Their brand sells capsules, tinctures, sprays, topicals, gummy’s, and CBD oil in bulk from their website as well...
Hemp News Market Watch

Marijuana Company of America’s hempSMART™ Brand Announces Strategic Partnership with “As Seen on TV” to Launch Commercial Ad Campaign

Editor
Marijuana Company of America (OTC: MCOA) has announced this morning that its wholly owned subsidiary hempSMART™ is launching a direct response television ad campaign in a strategic partnership with asseenontv.pro (ASONTV). In early November 2018, ASONTV and hempSMART will release a television commercial campaign promoting the hempSMART’s Full Spectrum Pet Drops,...
Current News Growers

Hemp Harvest Underway at mCig’s CBD Hemp Operation in New York

Editor
mCig, Inc. (OTCQB: MCIG) announced this morning that the company’s CBD industrial hemp farm in New York is being harvested this month. This seasons hemp crop, which is being grown orchard style, has been propagated to produce Cannabidiol (CBD) oil in order to manufacture products for the growing demand in...
Cannabis News Hemp News Market Watch

Canopy Growth Invests C$429 million to Acquire IP Advancements from Ebbu, Inc.

Editor
Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) announced this morning that the company has agreed with Ebbu, Inc. to acquire IP and R&D advancements in exchange for C$429 million dollars in cash and stock. Canopy Growth Corp. believes that the acquisition will benefit a number of different vertically integrated assests...
Hemp News Market Watch

United States Cannabinoid Extraction Company Mile High Labs Raises $35 Million

Editor
The Colorado based private cannabinoid extraction company Mile High Labs has announced that their company has completed a $35 million Series A financing from institutional and private equity investors in the United States. Mile High Labs is planning to use the newly acquired capital to expand the company’s ability to...
Current News Growers

Harvest Underway at Global Hemp Group’s CBD Hemp Project in Scio Oregon

Editor
Global Hemp Group Inc. (CSE: GHG / OTC: GBHPF / FRANKFURT: GHG) and its joint venture partner Marijuana Company of America, Inc. (OTC: MCOA) provided an update on their high yielding CBD hemp project in Scio, Oregon this morning. Harvest Harvest has begun at the farm. Over the next 10...
Politics

DEA Gives CBD Derived Pharmaceutical, Epidiolex, Approval as a Schedule V Drug

Editor
The Drug Enforcement Administration (DEA) has given the Cannabidiol (CBD) derived pharmaceutical product, Epidiolex, a reported Schedule V status. The newly approved drug is an oral solution that is used for the reduction of seizures associated with Lennox-Gastaut syndrome and Dravet syndrome. The CBD product Epidiolex is derived from the cannabis...